o.t) 5 Drugs awaiting FDA approval (Mcap 47 M)=RALLYYYYYYYYYYYYYYY
BREAKOUT STARTS ..ENJOY THE RIDE INTO DOUBLE DIGITS. GLTA
This Unknown low float Stock awaiting 5 FDA approvals and will rise to 7 by year end .IPCI has 15 Drugs in Pipeline many nearing ANDA/NDA filing including a potential Blockbuster .
Market Cap 47 Mil / Cash 13 M / Burn-rate 4.5 M per Year = They have enough cash to run their Company into profitable business .
2 FDA approvals and a New Partnership coming any day now .
MY Target is $15++ for 2011..A FANTASTIC INVESTMENT FOR BIO-FANS .
Market Cap: 47 M Cash: 13 M Price: 3.05 $
Shares Out: 15.9 Mil....(13 Mil Shares held by Insiders)
"The filing of a generic version of Seroquel XR® is one of the Company's performance milestones for 2011 and another important addition to our product portfolio filed for approval with the FDA, which includes generics of Focalin XR®, Effexor XR®, Protonix® DR and Glucophage® XR," commented Dr. Isa Odidi, CEO of Intellipharmaceutics. "These filings not only provide further validation of our Hypermatrix™ technology, they clearly demonstrate the flexibility of our technology to efficiently and effectively match a number of drug delivery profiles."
Intellipharmaceutics now has five ANDAs awaiting FDA approval with reported sales for branded and generic versions of these products being approximately $8 billion in 2010. The Company develops both ANDA product candidates and new drugs through the New Drug Application (NDA) 505(b)(2) regulatory pathway.
this is a retirement stock. this stock hunts. not unknown to many. my truck already 3/4 loaded since March/April. low float ~15-20M shares, focused management. compared to the rest of the posts on this tired, worn out board, the IPCI post is tits.